Check-Cap Ltd.

The positive Phase III results and subsequent US approval of lecanemab for Alzheimer’s disease was reflected by a spike in enthusiasm for the central nervous system (CNS) space among the 90 or so resp

Telehealth took a giant leap forward when the COVID-19 pandemic arrived on the scene in early 2020. The need for strict social distancing had an almost overnight effect on access to health care facili

"COVID-19 is a great reminder and a testament that biopharma's core mission is to meet patient and society's needs." These words of Lihua Yu , president and chief data science officer of Eisai Co.,

"The coming year will be remembered for the epic alteration to our society." These words from Pam Contag , CEO and co-founder of BioEclipse Therapeutics, Inc. , encapsulate the enormity of COVID-19'